Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shantanu Pande. (2023) Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 428-440.
Read now
Read now
Wanfu Men, Peiyao Zhu, Siyuan Dong, Wenke Liu, Kun Zhou, Yu Bai, Xiangli Liu, Shulei Gong, Can Yang Zhang & Shuguang Zhang. (2019) Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release. International Journal of Nanomedicine 14, pages 8001-8011.
Read now
Read now
Articles from other publishers (20)
Zhounan Qian, Yang Zhang, Jie Yuan, Sun Gong & Binghai Chen. (2023) Current applications of nanomaterials in urinary system tumors. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Ruolin Wu, Keshan Wang, Yongkang Gai, Mengting Li, Jingjing Wang, Chenyang Wang, Yajing Zhang, Zhiwei Xiao, Dawei Jiang, Zairong Gao & Xiaotian Xia. (2023) Nanomedicine for renal cell carcinoma: imaging, treatment and beyond. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, Nasim Rashedi, Saeideh Allahyari & Nastaran Hashemzadeh. 2023. Principles of Biomaterials Encapsulation : Volume Two. Principles of Biomaterials Encapsulation : Volume Two
589
660
.
Ali Abdel-Wahab. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
33
.
Poonam Yadav, Chhavi Dua & Avinash Bajaj. (2022) Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy. The Chemical Record 22:12.
Crossref
Crossref
Narayan Acharya & Kamaleshwar P. Singh. (2022) Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma. WIREs Mechanisms of Disease 14:6.
Crossref
Crossref
Jeongbin Park, Jinyeong Choi, Jae Eun Lee, Hongyoon Choi & Hyung‐Jun Im. (2022) Spatial Transcriptomics‐Based Identification of Molecular Markers for Nanomedicine Distribution in Tumor Tissue. Small Methods 6:11, pages 2201091.
Crossref
Crossref
Julio A. Vallejo-Zamora, Yadira I. Vega-Cantu, Ciro Rodriguez, Geoffrey A. Cordell & Aida Rodriguez-Garcia. (2022) Drug-Eluting, Bioresorbable Cardiovascular Stents─Challenges and Perspectives. ACS Applied Bio Materials 5:10, pages 4701-4717.
Crossref
Crossref
Shiyong Li, Ye Wang, Miaojin Wu, Muhsin H. Younis, Aeli P. Olson, Todd E. Barnhart, Jonathan W. Engle, Xingen Zhu & Weibo Cai. (2022)
Spleen‐Targeted Glabridin‐Loaded Nanoparticles Regulate Polarization of Monocyte/Macrophage (
M
o
/
M
φ
) for the Treatment of Cerebral Ischemia‐Reperfusion Injury
. Advanced Materials 34:39, pages 2204976.
Crossref
Crossref
Aishwarya Shinde, Kanan Panchal, Sumeet Katke, Rishi Paliwal & Akash Chaurasiya. (2022) Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives. Therapies 77:4, pages 425-443.
Crossref
Crossref
Yaw Opoku-Damoah, Run Zhang, Hang T. Ta & Zhi Ping Xu. (2021) Vitamin E-facilitated carbon monoxide pro-drug nanomedicine for efficient light-responsive combination cancer therapy. Biomaterials Science 9:18, pages 6086-6097.
Crossref
Crossref
Dan Bai, Huhu Feng, Jiajun Yang, Aiping Yin, Xiao Lin, Airong Qian & Hiroshi Sugiyama. (2021) Genomic analysis uncovers prognostic and immunogenic characteristics of ferroptosis for clear cell renal cell carcinoma. Molecular Therapy - Nucleic Acids 25, pages 186-197.
Crossref
Crossref
Carolin Langer & Regine Süss. (2021) HPLC-DAD-CAD-based approach for the simultaneous analysis of hydrophobic drugs and lipid compounds in liposomes and for cyclodextrin/drug inclusion complexes. Journal of Pharmaceutical and Biomedical Analysis 201, pages 114120.
Crossref
Crossref
Sunita Dahiya & Rajiv Dahiya. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
467
497
.
Hongyu Liu, Qingshan Fu, Yao Lu, Wenqiang Zhang, Peng Yu, Zhen Liu & Xiaosheng Sun. (2020) Anti-tubulin agent vinorelbine inhibits metastasis of cancer cells by regulating epithelial-mesenchymal transition. European Journal of Medicinal Chemistry 200, pages 112332.
Crossref
Crossref
Alexander A. Yaroslavov & Andrey V. Sybachin. (2020) Multifunctional carriers for controlled drug delivery. Pure and Applied Chemistry 92:6, pages 919-939.
Crossref
Crossref
Vijay Sagar Madamsetty, Krishnendu Pal, Shamit Kumar Dutta, Enfeng Wang & Debabrata Mukhopadhyay. (2020) Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer. Cancers 12:5, pages 1189.
Crossref
Crossref
Anubhab Mukherjee, Vijay Sagar Madamsetty, Manash K. Paul & Sudip Mukherjee. (2020) Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer. International Journal of Molecular Sciences 21:2, pages 455.
Crossref
Crossref
Neha Atale & Vibha Rani. 2020. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
165
183
.
Krishnendu Pal, Vijay Sagar Madamsetty, Shamit Kumar Dutta, Enfeng Wang, Ramcharan Singh Angom & Debabrata Mukhopadhyay. (2019) Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer. npj Precision Oncology 3:1.
Crossref
Crossref